Skip to content
20-F

Annual Report (Foreign)

Zepp Health Corp ZEPP

0001410578-25-000903

← back to feed
Filed
Apr 25, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Eps Diluted FY 2024 · Dec 31, 2024 −¥0.29
Eps Diluted restated FY 2024 · Dec 31, 2023 −¥0.13
Eps Diluted restated FY 2024 · Dec 31, 2022 −$0.18
Eps Diluted restated FY 2024 · Dec 31, 2022 −¥0.18
Eps Basic FY 2024 · Dec 31, 2024 −¥0.29
Eps Basic restated FY 2024 · Dec 31, 2023 −¥0.13
Eps Basic restated FY 2024 · Dec 31, 2022 −$0.18
Eps Basic restated FY 2024 · Dec 31, 2022 −¥0.18
Long Term Debt FY 2024 · Dec 31, 2023 $120.02M
Short Term Investments FY 2024 · Dec 31, 2023 $5.15M
Stockholders Equity restated FY 2024 · Dec 31, 2023 $350.88M
Current Liabilities FY 2024 · Dec 31, 2023 $155.11M
Total Liabilities FY 2024 · Dec 31, 2023 $282.77M
Current Assets FY 2024 · Dec 31, 2023 $316.73M
Total Assets FY 2024 · Dec 31, 2023 $635.52M
Shares Diluted FY 2024 · Dec 31, 2022 246.28M sh
Stock Repurchased restated FY 2024 · Dec 31, 2022 $8.16M
Capex restated FY 2024 · Dec 31, 2022 $1.21M
Operating Cash Flow restated FY 2024 · Dec 31, 2022 −$117.11M
Cash And Equivalents FY 2024 · Dec 31, 2022 $128.55M
Sga Expense restated FY 2024 · Dec 31, 2022 $35.11M
Rd Expense restated FY 2024 · Dec 31, 2022 $77.3M
Net Income restated FY 2024 · Dec 31, 2022 −$43.24M
Operating Income restated FY 2024 · Dec 31, 2022 −$61.86M
Gross Profit restated FY 2024 · Dec 31, 2022 $118.86M
Revenue restated FY 2024 · Dec 31, 2022 $613.64M